9
General Information
DRACP ID DRACP04814
Peptide Name 9
Sequence YSX
Sequence Length 3
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic
Disulfide/Other Bond Native peptide
N-terminal Modification Free
C-terminal Modification Free
Other Modification X=Cα -dialkylated glycine (Aaa2,2 )
Chiral L
Physicochemical Information
Formula C12H14N2O4
Absent amino acids ACDEFGHIKLMNPQRTVW
Common amino acids SYX
Mass 39610
Pl 6.09
Basic residues 0
Acidic residues 0
Hydrophobic residues 0
Net charge 0
Boman Index -354
Hydrophobicity -70
Aliphatic Index 0
Half Life
/
Extinction Coefficient cystines 1490
Absorbance 280nm 745
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 16722632
Title Not available
Doi Not available
Year Not available
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
CancerPPD ID 3872
CancerPPD ID 3873
CancerPPD ID 3874
CancerPPD ID 3875
CancerPPD ID 3876
CancerPPD ID 3877
CancerPPD ID 3878
CancerPPD ID 3879
CancerPPD ID 3880
CancerPPD ID 3881
CancerPPD ID 3882
CancerPPD ID 3883
CancerPPD ID 3884
CancerPPD ID 3885
CancerPPD ID 3886
CancerPPD ID 3887
CancerPPD ID 3888
CancerPPD ID 3889
CancerPPD ID 3890
CancerPPD ID 3891
CancerPPD ID 3892
CancerPPD ID 3893
CancerPPD ID 3894
CancerPPD ID 3895
CancerPPD ID 3896
CancerPPD ID 3897
CancerPPD ID 3898
CancerPPD ID 3899
CancerPPD ID 3900